Table 1 Clinicopathological characteristics of prostate cancer patients utilized in 2-DE Western blot experiments
From: Effects of oxygen on the antigenic landscape of prostate cancer cells
Age at surgery | |
 Number of cases | 25 |
 Mean (SD) | 61.5 (4.58) |
 Median age, years (range) | 61.0 |
 Q1, Q3 | 58.0, 65.0 |
 Range | (55.0–72.0) |
Pre-op PSA | |
 Mean (SD) | 5.8 (3.91) |
 Median age, years (range) | 5.0 |
 Q1, Q3 | 4.0, 6.3 |
 Range | (1.7–20.5) |
Clinical grade (GLEASON) | |
 Missing | 0 (%) |
 6 | 24 (96 %) |
 7 | 1 (4 %) |
 8 | 0 (%) |
 9 | 0 (%) |
Clinical T-stage, 1997 TNM | |
 Missing | 0 (%) |
 T1C | 16 (64 %) |
 T2a | 9 (36 %) |
 T2b | 0 (%) |
 T34 | 0 (%) |
Pathologic grade (GLEASON) | |
 Missing | 0 (%) |
 6 | 25 (100 %) |
 7 | 0 (%) |
 8 | 0 (%) |
 9 | 0 (%) |
Pathologic stage, 1997 TNM | |
 Missing | 0 (%) |
 T2aN0 | 8 (32 %) |
 T2bN0 | 17 (68 %) |
 T3aN0 | 0 (%) |
 TxN+ | 0 (%) |
Treatment-prior to surgery | |
 Missing | 0 (%) |
 No | 25 (100 %) |